- Opportunity and Forecast, 2016-2025
Yeast extract is processed yeast product made up of extracted cell contents. It is primarily used as food additives, flavoring agents, and nutrients in bacterial culture media. It contains a mixture of amino acids, water soluble vitamins, peptides, and carbohydrates. Savory flavors and taste sensations are created with the help of yeast extracts. Changes in lifestyle has increased the demand for the usage of processed and packaged foods. Therefore, the requirement for yeast extract also experiences growth owing to benefits it provides in yeast extracts including flavor enhancement. It is also used as a nutritional source in microbial culture media.
Growth in demand for natural ingredients, increase in consumption of dairy products, and rise in health awareness are the factors that drive the growth of the global yeast extract market. Adoption of processed food and increase in per capita disposable income supplements the growth. Whereas imbalance in supply demand of raw materials is projected to hinder the growth of the industry in the coming years. On the other hand, increase in utilization in poultry applications and changes in lifestyle preferences are expected to present opportunities in the industry. Regionally, the industry is subdivided into North America, Europe, Latin America, Asia-Pacific, Middle East, and Africa.
Key market players operating in the industry are Biospringer, Kerry, DSM, Lallemand, Ohly, Leiber, Biorigin, Sensiment, and Kohjin Life Sciences. These key industry players have adopted strategies, which include partnerships, collaborations, joint ventures, new product launches, expansion, merger & acquisition, and others to strengthen their competitive edge and position in the industry.
The global monoclonal antibody market was valued at $76,899 million in 2014 and is estimated to reach $214,922 million by 2025, registering a CAGR of 9.8% from 2018 to 2025. Read More >>